Table 1.
Principal secondary metabolites produced by Aspergillus korhogoensis.
Metabolite | Elemental Composition | m/z | Ion | Retention Time (min) | MS/MS | Error (ppm) | ID Level * | References |
AFLATOXIN BIOSYNTHESIS PATHWAY | ||||||||
Aflatoxin B1 | C17H12O6 | 313.07 | [M + H]+ | 17.37 | 285 (100), 298, 284, 270, 257, 243, 229 | −0.398 | 1, 2 | [25] |
Aflatoxin B2 | C17H14O6 | 315.07 | [M + H]+ | 14.95 | 297, 287 (100), 259, 269, 273 | −5.920 | 1, 2 | [25] |
Aflatoxin G1 | C17H12O7 | 329.08 | [M + H]+ | 15.25 | 311 (100), 301, 300, 283, 243 | −0.119 | 1, 2 | [25] |
Aflatoxin G2 | C17H14O7 | 331.08 | [M + H]+ | 12.84 | 313 (100), 303, 285, 275, 257, 245 | −0.511 | 1, 2 | [25] |
O-methyl-sterigmatocystin | C19H14O6 | 339.08 | [M + H]+ | 24.21 | 324 (100), 311, 306, 295 | 2.817 | 1 | |
Sterigmatocystin | C18H12O6 | 325.07 | [M + H]+ | 33.59 | 310 (100), 297, 282 | 0.570 | 1, 2 | [26] |
Versicolorin A | C18H10O7 | 337.03 | [M − H]− | 35.95 | 309 (100), 319, 308, 293, 265, 253 | −2.094 | 1, 2 | [27] |
Versicolorin B | C18H12O7 | 339.05 | [M − H]− | 34.40 | 311 (100) 310, 309, 295, 297, 283 | −0.578 | 1, 2 | [27] |
Norsolorinic acid | C20H18O7 | 369.10 | [M − H]− | 42.07 | 351 (100), 341, 325, 308, 297, 270 | 1.528 | 1 | |
CYCLOPIAZONIC ACID BIOSYNTHETIC PATHWAY | ||||||||
α-cyclopiazonic acid | C20H20N2O3 | 337.15 | [M + H]+ | 36.77 | 182 (100), 196, 154, 140 | 0.561 | 1, 2 | [28] |
β-cyclopiazonic acid | C20H22N2O3 | 339.17 | [M + H]+ | 37.58 | 198 (100), 324, 283, 183, 144, 130 | −1.289 | 2 | [28] |
2′-oxo-cyclopiazonic acid | C20H20N2O4 | 353.15 | [M + H]+ | 36.20 | 335 (100), 311, 293, 252, 224, 212 | −1.174 | 2 | [28] |
3′-hydroxy-speradine A | C21H22 N2O5 | 383.16 | [M + H]+ | 21.19 | 355 (100), 365, 182, 184, 226, 254, 323, 347, 337 | −1.144 | 2 | [28] |
Speradine C | C20H22 N2O5 | 371.16 | [M + H]+ | 18.19 | 353 (100), 287, 269, 259, 226, 184 | 2.780 | 2 | [28] |
Speradine D | C20H22 N2O6 | 387.16 | [M + H]+ | 20.80 | 369 (100), 269, 226, 184 | 2.679 | 2 | [28] |
Speradine F | C21H22 N2O7 | 415.15 | [M + H]+ | 18.99 | 397 (100), 379, 369, 355, 353, 337, 311, 297, 281, 269, 253, 226, 184 | −0.644 | 2 | [28] |
Cyclopiamide J | C22H24N2O7 | 429.17 | [M + H]+ | 23.96 | 287 (100), 411, 497, 379, 369, 337, 269, 259, 226, 184 | −0.693 | 2 | [28] |
KOJIC ACID BIOSYNTHETIC PATHWAY | ||||||||
Kojic acid | C6H6O4 | 143.03 | [M + H]+ | 1.87 | 143 (100) 125, 113, 97 | 1.432 | 1, 2 | [29] |
AFLATREM BIOSYNTHETIC PATHWAY | ||||||||
α-aflatrem | C32H39NO4 | 502.29 | [M + H]+ | 41.45 | 444 (100), 484, 426, 412, 376, 198 | 1.144 | ||
Paspalinine | C27H31NO4 | 434.23 | [M + H]+ | 39.22 | 376 (100), 416, 419, 362, 358, 344, 130 | 0.726 | 2 | [30] |
Paspaline | C28H39NO2 | 422.31 | [M + H]+ | 43.96 | 130 (100), 404, 407 | −0.583 | 2 | [30] |
Hydroxyaflatrem | C32H39NO5 | 518.29 | [M + H]+ | 38.22 | 460 (100), 500, 482, 442, 446, 428 | −0.347 | ||
Paxilline | C27H33NO4 | 436.25 | [M + H]+ | 38.64 | 418 (100), 421, 400, 378, 360, 346, 130 | −2.762 | 1, 2 | [30] |
13′-desoxypaxilline | C27H33NO3 | 420.25 | [M + H]+ | 40.31 | 402 (100), 405, 362, 130 | −0.320 | 2 | [30] |
ASPARASONE BIOSYNTHESIS PATHWAY | ||||||||
Asparasone A | C18H14O8 | 357.06 | [M − H]− | 22.13 | 339 (100) 299 | 1.315 | 2 | [31] |
1,3,4,6,8 pentahydroxy-2-(1′-hydroxy-3′-oxobuty)anthraquinone | C18H14O9 | 373.04 | [M − H]− | 9.36 | 355 (100) 315 | 0.629 | 2 | [31] |
1,3,6,8 tetrahydroxy-2-(1′-hydroxyethyl) anthraquinone | C16H1207 | 315.05 | [M − H]− | 27.98 | 297 (100) | 0.775 | 2 | [31] |
1,3,6,8 tetrahydroxy-2-(3′ oxobut 1′-en-1′-yl) anthraquinone | C18H1207 | 339.05 | [M − H]− | 29.77 | 297 (100) 321, 296, 295, 311, 306 | 1.428 | 2 | [31] |
LEPORINS BIOSYNTHESIS PATHWAY | ||||||||
Leporin B | C22H25NO3 | 352.19 | [M + H]+ | 40.78 | 216 (100), 230, 244, 258, 270, 282, 296, 306 | −1.505 | 2 | [25] |
Leporin B precursor | C22H25NO2 | 336.20 | [M + H]+ | 37.97 | 200 (100), 214, 228, 242, 254, 266, 280 | 0.102 | 2 | [25] |
AFLAVARIN BIOSYNTHESIS PATHWAY | ||||||||
Aflavarin | C24H22O9 | 455.13 | [M + H]+ | 18.22 | 413 (100), 425, 437, 395, 379, 364, 348, 303 | −3.732 | 1, 2 | [32] |
7′-demethyl-siderin | C11H10O4 | 207.07 | [M + H]+ | 13.58 | 163 (100), 177, 175, 148, 147, 135, 133, 131, 115, 107 | 0.312 | 2 | [32] |
Aflavarin precursor 6 | C22H18O8 | 411.11 | [M + H]+ | 20.69 | 369 (100), 381, 379, 352, 343, 337, 279, 207, 177, 147 | −0.569 | 2 | [32] |
Aflavarin precursor 5 | C23H20O8 | 425.12 | [M + H]+ | 26.75 | 383 (100), 393, 369, 363, 357, 349 | 0.484 | 2 | [32] |
Aflavarin precursor 4 | C24H22O8 | 439.14 | [M + H]+ | 30.52 | 397 (100), 383, 371, 367, 365, 351, 341, 321 | −0.624 | 2 | [32] |
AFLAVININE BIOSYNTHESIS PATHWAY | ||||||||
20′-hydroxyaflavinine | C28H39O2N | 404.29 | [M − H2O + H]+ | 37.53 | 386 (100), 287, 269, 243, 144, 130 | 0.071 | 1 | |
Unknown aflavanine | C28H39O2N | 404.29 | [M − H2O + H]+ | 38.14 | 386 (100), 287, 269, 224 | 0.170 |
* ID Level 1: Metabolites that displayed the same retention time, UV and MS/MS spectra than the authentic standard. Level 2: Metabolites that displayed the same UV spectrum and/or the same MS/MS fragmentation pattern in accordance with the literature.